Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
October 10, 2024
CAMP4 Announces Pricing of Initial Public Offering
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
October 25, 2019
Press Releases
Richard Young, Ph.D., Founder of CAMP4 Therapeutics, Elected to National Academy of Medicine
January 23, 2019
Press Releases
CAMP4 Therapeutics Announces Rare Disease Research Collaboration with Alnylam
May 31, 2018
Press Releases
CAMP4 Therapeutics Launches with Platform to Discover Effective Treatment Approaches for Every Disease, Announces $30 Million Series A Financing
«
1
2
3
Media Contact:
PR@camp4tx.com
Top
